Atyr Pharma, Stock Analysis

ATyr Stock Analysis Notes

About 64.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.76. Some equities with similar Price to Book (P/B) outperform the market in the long run. aTyr Pharma, recorded a loss per share of 0.9. The entity had not issued any dividends in recent years. The firm had 1:14 split on the 1st of July 2019. For more info on aTyr Pharma, please contact MS MD at 858 731 8389 or go to https://www.atyrpharma.com.

aTyr Pharma, Investment Alerts

ATyr Largest EPS Surprises

View All Earnings Estimates

ATyr Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 144.01 M.

ATyr Profitablity

Management Efficiency

aTyr Pharma, has return on total asset (ROA) of (0.3274) % which means that it has lost $0.3274 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6176) %, meaning that it created substantial loss on money invested by shareholders. ATyr Pharma,'s management efficiency ratios could be used to measure how well ATyr Pharma, manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/28/2024, Return On Tangible Assets is likely to drop to -0.44. In addition to that, Return On Capital Employed is likely to drop to -0.55. At this time, ATyr Pharma,'s Other Current Assets are relatively stable compared to the past year. As of 11/28/2024, Non Currrent Assets Other is likely to grow to about 139 K, while Total Assets are likely to drop slightly above 101.9 M.

Technical Drivers

As of the 28th of November, ATyr Pharma, shows the Risk Adjusted Performance of 0.1761, semi deviation of 2.7, and Downside Deviation of 3.41. aTyr Pharma, technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm aTyr Pharma, jensen alpha and semi variance to decide if aTyr Pharma, is priced correctly, providing market reflects its regular price of 3.44 per share. Given that ATyr Pharma, has jensen alpha of 0.9356, we suggest you to validate aTyr Pharma,'s prevailing market performance to make sure the company can sustain itself at a future point.

aTyr Pharma, Price Movement Analysis

aTyr Pharma, Insider Trading Activities

ATyr Pharma, Predictive Daily Indicators

ATyr Pharma, Forecast Models

ATyr Pharma,'s time-series forecasting models are one of many ATyr Pharma,'s stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ATyr Pharma,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how ATyr Pharma, prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ATyr shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as ATyr Pharma,. By using and applying ATyr Stock analysis, traders can create a robust methodology for identifying ATyr entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. ATyr analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. ATyr analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

aTyr Pharma, stock analysis indicators help investors evaluate how ATyr Pharma, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading ATyr Pharma, shares will generate the highest return on investment. By understating and applying ATyr Pharma, stock analysis, traders can identify ATyr Pharma, position entry and exit signals to maximize returns.

When running ATyr Pharma,'s price analysis, check to measure ATyr Pharma,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATyr Pharma, is operating at the current time. Most of ATyr Pharma,'s value examination focuses on studying past and present price action to predict the probability of ATyr Pharma,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATyr Pharma,'s price. Additionally, you may evaluate how the addition of ATyr Pharma, to your portfolios can decrease your overall portfolio volatility.